The effect of zoledronic acid in the prevention of aromatase inhibitor-associated bone loss on postmenopausal women with early breast cancer receiving adjuvant letrozol: the Z-FAST study 36-months follow-up. - Brufsky,A.; Harker,G.; Beck,T. (Cancer Res, 2009)